
HIV 1 group M subtype K (isolate 96CM-MP535) Gag 256-262, EIYKRWII
Description
About HIV 1 group M subtype K (isolate 96CM-MP535) Gag 256-262, EIYKRWII
The Human immunodeficiency virus (HIV) type 1 group M subtype K (isolate 96CM-MP535) Gag polyprotein (gag) Peptide (IEDB: 12616) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Gag polyprotein (gag) Peptide, H-EIYKRWII-OH (Uniprot: Q9QBY4 aa: 256-262) from JPT is produced under strict quality control and quality management.
HIV 1 group M subtype K (isolate 96CM-MP535) Gag 256-262, EIYKRWII - Specifications
- Peptide sequence: H-EIYKRWII-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): AIDS (HIV)
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for HIV 1 group M subtype K (isolate 96CM-MP535) Gag 256-262, EIYKRWII
References:
Read References with JPT’s Antigen Peptides
HIV 1 group M subtype K (isolate 96CM-MP535) Gag 256-262, EIYKRWII has been described in:
Lack of Epstein-Barr virus- and HIV-specific CD27- CD8+ T cells is associated with progression to viral disease in HIV-infection., AIDS, 2002 (PMID: 12370498)
Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells., Eur J Immunol, 2002 (PMID: 11920575)
Phase I trial of recombinant modified vaccinia ankara encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patients., Cancer Res, 2013 (PMID: 23348421)
Documentation
Documentation for HIV 1 group M subtype K (isolate 96CM-MP535) Gag 256-262, EIYKRWII
Properties
Properties of HIV 1 group M subtype K (isolate 96CM-MP535) Gag 256-262, EIYKRWII
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | AIDS (HIV) |
Layout: | Freeze-dried in glass vial |
Organism: | Human immunodeficiency virus (HIV) |
Protein Name: | Gag polyprotein (gag) |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to HIV 1 group M subtype K (isolate 96CM-MP535) Gag 256-262, EIYKRWII
Information | Values |
---|---|
Sequence: | H-EIYKRWII-OH |
Specifications: | 8mer peptide as TFA salt |